Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug
Background: COVID-19 disease caused by SARS-CoV-2 is lacking efficient medication although certain medications are used to relief its symptoms. Objectives: We tested an FDA-approved antiviral medication namely rilpivirine to find a drug against SARS-CoV-2. Methods: The inhibition of rilpivirine agai...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-10-01
|
| Series: | Journal of Infection and Public Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034121001994 |